Compositions and methods for the transfer of a hexosamine to a modified nucleotide in a nucleic acid
First Claim
Patent Images
1. A cell free composition comprising:
- an isolated DNA β
-glucosyltransferase;
UDP-glucosamine (UDP-GlcN); and
a restriction enzyme capable of cleaving a nucleic acid at a site comprising β
-glucosyl-5-hydroxymethylcytosine but not a site comprising β
-2-glucosaminyl-5-hydroxymethylcytosine.
2 Assignments
0 Petitions
Accused Products
Abstract
Nucleic acids comprising β-glucosaminyloxy-5-methylcytosine; compositions, kits and methods of producing the nucleic acids using a glycosyltransferase; and methods of using the nucleic acids are described.
-
Citations
7 Claims
-
1. A cell free composition comprising:
-
an isolated DNA β
-glucosyltransferase;UDP-glucosamine (UDP-GlcN); and a restriction enzyme capable of cleaving a nucleic acid at a site comprising β
-glucosyl-5-hydroxymethylcytosine but not a site comprising β
-2-glucosaminyl-5-hydroxymethylcytosine. - View Dependent Claims (2, 3)
-
-
4. A cell free kit comprising:
-
a DNA β
-glucosyltransferase;UDP-GlcN; and a restriction enzyme capable of cleaving a nucleic acid at a site comprising β
-glucosyl-5-hydroxymethylcytosine but not a site comprising β
-2-glucosaminyl-5-hydroxymethylcytosine.
-
-
5. A method for labeling a modified nucleotide in a nucleic acid, comprising:
-
(a) combining; i. a nucleic acid having a modified nucleotide ii. an isolated DNA β
-glucosyltransferase; andiii. UDP-glucosamine (UDP-GlcN), to produce a mixture; and (b) incubating the mixture under conditions permitting the glucosamine to become covalently attached to the modified nucleotide in the nucleic acid; and (c) adding to the mixture; iv. a restriction enzyme capable of cleaving a nucleic acid at a site comprising β
-glucosyl-5-hydroxymethylcytosine but not a site comprising β
-2-glucosaminyl-5-hydroxymethylcytosine. - View Dependent Claims (6, 7)
-
Specification